Matthew J. Kuhn1, Bryce K. Young1,
N
1Radiology, University of Illinois at
Peoria, Peoria, IL, United States; 2Radiology, Southern Illinois
University, Springfield, Ilinois, United States; 3Radiology,
Southern Illinois University, Springfield, IL, United States
As
part of an ongoing prospective multicenter study to determine the incidence
of NSF in patients with stages 3 to 5 chronic kidney disease (CKD) undergoing
magnetic resonance imaging (MRI) of the central nervous system with
gadobenate dimeglumine, 223 patients have been enrolled at 15 sites. Patients
are followed for 2 years with a regular schedule of telephone calls and
visits. To date, no case of NSF has
been reported, although follow-up is ongoing in most of these patients.